RECELL system approved to treat severe burns
From Sept. 28:
AVITA Medical announced that the Food and Drug Administration (FDA) has approved the Premarket Approval (PMA) application to market the RECELL Autologous Cell Harvesting Device to treat thermal burns in patients aged ≥18 years. The RECELL System is intended for use at the point of care by trained healthcare professionals. It can be used alone for treating partial-thickness burns, or in combination with autografting to treat full-thickness burns.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063